Cognitive slowing in Parkinson's disease is related to frontostriatal dopaminergic dysfunction

Journal of the Neurological Sciences

Volumn 329, Issue 1-2, 2013, Pages 23-28

  Jokinen, Pekka ^a   Karrasch, Mira ^b   Brück, Anna ^a   Johansson, Jarkko ^a   Bergman, Jörgen ^c   Rinne, Juha O ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Cognition; Fdopa; Parkinson's disease; PET

Indexed keywords

6 FLUORODOPA F 18;

ADULT; AGED; ANTERIOR CINGULATE; ARTICLE; CALCULATION; CAUDATE NUCLEUS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC DYSFUNCTION; FEMALE; FRONTAL CORTEX; HUMAN; MALE; MENTAL PERFORMANCE; MENTAL TASK; NERVE CELL NETWORK; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; REACTION TIME; TASK PERFORMANCE; THALAMUS;

AGED; CHOICE BEHAVIOR; COGNITION DISORDERS; CORPUS STRIATUM; DIHYDROXYPHENYLALANINE; DOPAMINE; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; REACTION TIME; STATISTICS, NONPARAMETRIC;

EID: 84876688848     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2013.03.006     Document Type: Article

References (43)

1. G.E. Alexander, and M.D. Crutcher Functional architecture of basal ganglia circuits: neural substrates of parallel processing Trends Neurosci 13 7 1990 266 271
2. S.N. Haber, J.L. Fudge, and N.R. McFarland Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum J Neurosci 20 6 2000 2369 2382
3. A. Parent Extrinsic connections of the basal ganglia Trends Neurosci 13 7 1990 254 258
4. N. Sawamoto, P. Piccini, G. Hotton, N. Pavese, K. Thielemans, and D.J. Brooks Cognitive deficits and striato-frontal dopamine release in Parkinson's disease Brain 131 Pt. 5 2008 1294 1302
5. A.M. Owen Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry Neuroscientist 10 6 2004 525 537
6. E.R. Barbosa, J.C. Limongi, and J.L. Cummings Parkinson's disease Psychiatr Clin North Am 20 4 1997 769 790
7. B. Dubois, and B. Pillon Cognitive deficits in Parkinson's disease J Neurol 244 1 1997 2 8
8. A.M. Owen, M. James, P.N. Leigh, B.A. Summers, C.D. Marsden, and N.P. Quinn Fronto-striatal cognitive deficits at different stages of Parkinsons-disease Brain 115 1992 1727 1751
9. J. Koerts, K.L. Leenders, and W.H. Brouwer Cognitive dysfunction in non-demented Parkinson's disease patients: controlled and automatic behavior Cortex 45 8 2009 922 929
10. 18F]fluorodopa positron emission tomographic study Arch Neurol 57 4 2000 470 475
11. 18F]fluoro-l-dopa PET study Brain 125 Pt. 6 2002 1358 1365
12. 18F]fluoro-l-dopa uptake and frontal cognitive functions in early Parkinson's disease Neurobiol Aging 26 6 2005 891 898
13. J.S. Rakshi, T. Uema, K. Ito, D.L. Bailey, P.K. Morrish, and J. Ashburner Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease. A 3D [(18)F]dopa-PET study Brain 122 Pt. 9 1999 1637 1650
14. V. Kaasinen, E. Nurmi, A. Bruck, O. Eskola, J. Bergman, and O. Solin Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex Brain 124 Pt. 6 2001 1125 1130
15. W. Schneider, and R.M. Shiffrin Controlled and automatic human information processing: I. Detection, search, and attention Psychol Rev 84 1977 1 66
16. E.V. Evarts, H. Teravainen, and D.B. Calne Reaction time in Parkinson's disease Brain 104 Pt. 1 1981 167 186
17. A. Revonsuo, R. Portin, L. Koivikko, J.O. Rinne, and U.K. Rinne Slowing of information processing in Parkinson's disease Brain Cogn 21 1 1993 87 110
18. 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls J Nucl Med 50 6 2009 893 899
19. A.J. Hughes, S.E. Daniel, S. Blankson, and A.J. Lees A clinicopathological study of 100 cases of Parkinsons-disease Arch Neurol 50 2 1993 140 148
20. A. Revonsuo, and R. Portin Cognispeed: the computer based measurement of cognitive processing 1995
21. 18F]-fluoride 35 1994 476 477
22. M. Namavari, A. Bishop, N. Satyamurthy, G. Bida, and J.R. Barrio Regioselective radiofluorodestannylation with [F-18] F2 and [F-18] Ch3Coof - a high-yield synthesis of 6-[F-18]fluoro-l-dopa Appl Radiat Isot 43 8 1992 989 996
23. K.J. Friston, A.P. Holmes, K.J. Worsley, J.P. Poline, C.D. Frith, and R.S.J. Franckowiak Statistical parametric maps in functional imaging: a general linear approach Hum Brain Mapp 2 1995 189 210
24. A.S. Nagano, K. Ito, T. Kato, Y. Arahata, T. Kachi, and K. Hatano Extrastriatal mean regional uptake of fluorine-18-FDOPA in the normal aged brain - an approach using MRI-aided spatial normalization Neuroimage 11 6 Pt. 1 2000 760 766
25. K.J. Friston, A.P. Holmes, K.J. Worsley, J.P. Poline, C.D. Frith, and R.S.J. Franckowiak Statistical parametric maps in functional imaging. A general approach Hum Brain Mapp 1995 189 210
26. J.A. Maldjian, P.J. Laurienti, R.A. Kraft, and J.H. Burdette An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets Neuroimage 19 3 2003 1233 1239
27. N. Sawamoto, M. Honda, T. Hanakawa, H. Fukuyama, and H. Shibasaki Cognitive slowing in Parkinson's disease: a behavioral evaluation independent of motor slowing J Neurosci 22 12 2002 5198 5203
28. V.A. Holthoff-Detto, J. Kessler, K. Herholz, H. Bonner, U. Pietrzyk, and M. Wurker Functional effects of striatal dysfunction in Parkinson disease Arch Neurol 54 2 1997 145 150
29. P. Jokinen, A. Bruck, S. Aalto, S. Forsback, R. Parkkola, and J.O. Rinne Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy Parkinsonism Relat Disord 15 2 2009 88 93
30. A. Bruck, R. Portin, A. Lindell, A. Laihinen, J. Bergman, and M. Haaparanta Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus Neurosci Lett 311 2 2001 81 84
31. J.A. Grahn, J.A. Parkinson, and A.M. Owen The cognitive functions of the caudate nucleus Prog Neurobiol 86 3 2008 141 155
32. M. Grossman, P. Crino, M. Reivich, M.B. Stern, and H.I. Hurtig Attention and sentence processing deficits in Parkinson's disease: the role of anterior cingulate cortex Cereb Cortex 2 6 1992 513 525
33. B. Faw Pre-frontal executive committee for perception, working memory, attention, long-term memory, motor control, and thinking: a tutorial review Conscious Cogn 12 1 2003 83 139
34. C. Polito, V. Berti, S. Ramat, E. Vanzi, M.T. De Cristofaro, and G. Pellicano Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's disease Neurobiol Aging 33 1 2012 206.e29 206.e39
35. S. Haber, and N.R. McFarland The place of the thalamus in frontal cortical-basal ganglia circuits Neuroscientist 7 4 2001 315 324
36. G.M. Halliday Thalamic changes in Parkinson's disease Parkinsonism Relat Disord 15 Suppl. 3 2009 S152 S155
37. S. Seifert, D.Y. von Cramon, D. Imperati, M. Tittgemeyer, and M. Ullsperger Thalamocingulate interactions in performance monitoring J Neurosci 31 9 2011 3375 3383
38. R. Cools, R.A. Barker, B.J. Sahakian, and T.W. Robbins l-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease Neuropsychologia 41 11 2003 1431 1441
39. K.W. Lange, G.M. Paul, T.W. Robbins, and C.D. Marsden l-Dopa and frontal cognitive function in Parkinson's disease Adv Neurol 60 1993 475 478
40. L. Fern-Pollak, A.L. Whone, D.J. Brooks, and M.A. Mehta Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease Neuropsychologia 42 14 2004 1917 1926
41. W.D. Brown, M.D. Taylor, A.D. Roberts, T.R. Oakes, M.J. Schueller, and J.E. Holden FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa Neurology 53 6 1999 1212 1218
42. D.J. Brooks Imaging non-dopaminergic function in Parkinson's disease Mol Imaging Biol 9 4 2007 217 222
43. 18F]FDOPA Psychiatry Res 163 2 2008 171 182